Background: Brugada syndrome (BrS) is a cardiac disorder characterized by conduction abnormalities that can lead to sudden death; syncope and cardiac arrest are clinical manifestations which are often associated with an enhancement of the vagal activity. Mutations in the SCN5A gene (Na 1.5 channel) are the most common cause of the inherited forms of BrS. Objective: To characterize the functional behavior of mutant Na 1.5 channels expressing a novel heterozygous mutation (S805L) recently identified in an Italian family affected by the BrS. Methods: HEK cells were used as experimental model to express both the wild-type (WT) and the mutated S805L channels (alone, Homo or in combination, Hetero) and the accessory β-subunit (SCN1B). Patch-clamp and western blot experiments were carried out to assess the dysfunctional role of the mutation. Results: When compared to the WT current, the S508L mutation significantly (P&It0.05) decreases the peak current density by about 65% for the Homo condition (WT: -120.2±10.2, n=28); Homo: -40.3±4.2, n=16) and by 35% for the Hetero condition (Hetero: -78.2±8.3, n=27). Densitometric analysis carried out on western blot data further support the conclusion that S805L channels are less abundant in the plasma membrane. We also observed that the S805L mutation positively shifts the V½ values of the voltage dependence of the inactivation of both Homo and Hetero currents (V½: WT -85.5±0.2 mV, n=55; Homo -80.9±0.3 mV, n=22; Hetero -81.9±0.2 mV, n=25; P&It0.05); a positive shift of the V½ of the activation was also observed but only in the Homo condition (V½: WT -33.0±0.4 mV, n=28; Homo -30.0±0.5, n=16, P&It0.05). The kinetics of recovery from inactivation Conclusion: When expressed in the Hetero condition, the S805L mutation causes a reduction inthe channel expression, however, the positive shift of the inactivation curve suggests an increase inNa channel availability. We thus believe that the precise quantitative balance between these twophenomena and their relation with vagal activity may underlie the clinical manifestation of thedisease.
Functional Characterization of a Novel Scn5a Mutation Associated With the Brugada Syndrome / A. Frosio, D. Molla, G. Bertoli, C. Bazzini, R. Milanesi, F. Gennaro, A.F. Barbuti, A. Bucchi, L. Moretti, P. Marchese, D. Di Francesco, M. Baruscotti. - In: CIRCULATION RESEARCH. - ISSN 1524-4571. - 125:Suppl. 1(2019 Oct 16). ((Intervento presentato al convegno American Heart Association's Basic Cardiovascular Sciences Scientific Sessions: Integrative Approaches to Complex Cardiovascular Diseases : August, 2nd nel 2019.
|Titolo:||Functional Characterization of a Novel Scn5a Mutation Associated With the Brugada Syndrome|
FROSIO, ANTHONY (Primo)
MOLLA, DAVID (Secondo)
DI FRANCESCO, DARIO (Penultimo)
BARUSCOTTI, MIRKO (Ultimo)
|Settore Scientifico Disciplinare:||Settore BIO/09 - Fisiologia|
|Data di pubblicazione:||16-ott-2019|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1161/res.125.suppl_1.808|
|Appare nelle tipologie:||01 - Articolo su periodico|